Lorazepam (Ativan) and diazepam (Valium) are two of the most widely prescribed benzodiazepines in the United States. Both are used to treat acute anxiety and calm the nervous system through the same basic mechanism, but they differ meaningfully in how fast they act, how long they stay in the body, and how the liver processes them.
Those differences can matter. They may shape which medication a prescriber reaches for, how doses are spaced across the day, and which people are better suited to one over the other. If your provider has prescribed benzodiazepines, it is helpful to know how lorazepam and diazepam compare and what safety considerations must be kept in mind.
Key Takeaways
Effect duration may be the most important practical difference: Diazepam and its active byproducts stay in the body far longer than lorazepam, so diazepam can offer steadier coverage while lorazepam tends to clear more predictably and may be easier to dose several times a day.
Lorazepam is processed differently by the liver: It bypasses the cytochrome P450 enzyme system entirely, which can make it a safer choice for people with liver problems, older adults, or anyone on a complicated medication list.
Both carry the same class warnings: In 2020, the FDA required an updated boxed warning across all benzodiazepines covering abuse, addiction, physical dependence, and withdrawal. Neither medication should be stopped abruptly, and both are generally intended for short-term use.
What Are Lorazepam and Diazepam?
Both medications belong to a class called benzodiazepines, which are used to treat acute anxiety symptoms associated with anxiety disorders over the short term. They also have other approved uses, including as pre-anesthesia medication for anxiety relief before surgery, and treating alcohol withdrawal (diazepam), seizures, and status epilepticus (a medical emergency involving a continuous seizure).
They work by enhancing the effect of gamma-aminobutyric acid (GABA), the brain’s main calming neurotransmitter. When GABA activity increases, nerve signaling slows down, which is why benzodiazepines reduce anxiety, relax muscles, help with sleep, and stop seizures.
Diazepam arrived first, developed in the 1960s, and became one of the most recognizable prescription medications of its era. Lorazepam followed in 1977 and gradually became a common choice of medication in both inpatient and outpatient settings, partly because of how neatly the body handles it.
Lorazepam (Ativan) and diazepam (Valium) sit alongside other benzodiazepines such as alprazolam (Xanax) and clonazepam (Klonopin), each with its own timing profile.
Lorazepam vs. Diazepam: Approved Uses
The two medications overlap considerably, but their FDA-approved indications are not identical. The differences reflect where each drug’s particular timing profile is most useful.
What Lorazepam is Approved For
The FDA has approved lorazepam for the management of anxiety disorders or the short-term relief of anxiety symptoms, including anxiety associated with depressive symptoms, anxiety-related insomnia, premedication before anesthesia to reduce anxiety or produce sedation, and treatment of status epilepticus, a prolonged seizure emergency.
Lorazepam is favored in hospital settings partly because of how quickly it works when given intravenously, often within one to three minutes. Common off-label uses include managing alcohol withdrawal, calming acute agitation, and treating chemotherapy-related nausea.
What Diazepam is Approved For
Diazepam has a somewhat broader label. Its FDA-approved uses include management of anxiety disorders and short-term relief of anxiety symptoms, spasticity related to upper motor neuron disorders such as cerebral palsy and paraplegia, muscle spasm as an add-on treatment, relief of preoperative anxiety, certain cases of hard-to-control epilepsy, and as an adjunct in certain seizure disorders.
Diazepam’s use as a muscle relaxant may be the clearest point of separation between the two benzodiazepines. For someone dealing with both anxiety and significant muscle spasm, diazepam can address both in one medication.
How Long Each Medication Lasts
This is another area where the two drugs diverge, and it can dictate prescribing decisions. The relevant concept is half-life, meaning how long the body takes to clear half of a dose.
Diazepam has a long half-life on its own (~46 hours), and it also produces active byproducts, including desmethyldiazepam, and minor active metabolites such as temazepam and oxazepam. Those byproducts have calming effects of their own and can linger well after the parent drug is gone, which stretches the total duration of action considerably. For instance, the average half-life of desmethyldiazepam is approximately 100 hours. This is largely why diazepam accumulates with repeated dosing, particularly in older adults and people with impaired liver function.
Lorazepam does not produce active byproducts. It is converted to an inactive form and cleared, which tends to make its effects more contained and more predictable dose to dose. This makes lorazepam a safer option for people with mild-to-moderate hepatic (liver) dysfunction.
The practical translation looks roughly like this:
Diazepam may provide longer, smoother coverage from a single dose, which can be an advantage when steady control is the goal. The trade-off can be greater buildup over days, more lingering grogginess, and slower clearance in older adults. At the same time, missing a single dose is generally less likely to cause a sudden drop in drug levels or trigger withdrawal symptoms.
Lorazepam wears off sooner, which usually means more doses per day but less accumulation. That predictability may be one reason it is often preferred in hospitals and for people whose bodies clear medications slowly. However, missed doses may lead to a faster return of anxiety symptoms or withdrawal effects in people who take it regularly.
Note: Neither medication should be stopped abruptly since benzodiazepines can cause serious withdrawal symptoms after regular use. In case of discontinuation, the dose must be tapered under provider’s guidance.
How the Liver Handles Each Drug
This difference is less visible to patients but can matter a great deal in practice. Most benzodiazepines are broken down by liver enzymes in the cytochrome P450 system, mainly CYP3A4 and CYP2C19. Diazepam follows that route.
Lorazepam does not. It undergoes a process called direct glucuronidation in the liver, skipping the P450 system entirely. That is largely why lorazepam may be used in people with liver dysfunction where other benzodiazepines could build up unpredictably. However, dosing may still require adjustment in severe liver impairment.
The same logic applies to drug interactions. Medications that inhibit or induce CYP3A4, including certain antifungals, antibiotics, and seizure medications, may raise or lower diazepam levels. Also, medications known to inhibit or induce CYP2C19, such as the antidepressant fluoxetine, certain antibiotics, and the steroid medication prednisone, can impact diazepam levels, which means concomitant use must be carefully monitored.
Lorazepam is far less affected by that kind of interference, which can make it a simpler choice for people already taking several prescriptions.
Speaking of drug interactions, both lorazepam and diazepam interact with opioids, central nervous system depressants, the antipsychotic medication clozapine, and alcohol, increasing the risk of excessive drowsiness and slowed breathing. These combinations are therefore generally avoided.
Side Effects of Lorazepam and Diazepam
Because both medications work the same way, their side effect profiles look similar. What varies is largely how long the effects last.
Common Side Effects
The most frequent effects for both drugs relate to central nervous system slowing:
Drowsiness and sedation
Dizziness or lightheadedness
Weakness or a sense of physical heaviness
Unsteadiness and reduced coordination
Trouble concentrating or short-term memory lapses
Slurred speech at higher doses
FDA labeling for lorazepam (Ativan) reports that among roughly 3,500 people treated for anxiety with lorazepam tablets, sedation was the most common reaction at about 16%, followed by dizziness at about 7%, weakness at about 4%, and unsteadiness at about 3%. Sedation and unsteadiness increased with age.
Because diazepam and its byproducts persist longer, next-day grogginess may be a more common complaint with diazepam, particularly with repeated dosing.
Risks in Older Adults
Both medications can increase the risk of falls, confusion, and memory problems in older adults, and both are generally used with caution in this group. Since diazepam’s long duration makes accumulation more likely, an intermediate-duration benzodiazepine such as lorazepam is often preferred over longer-acting agents like diazepam when a benzodiazepine is necessary.
Serious Risks to Know About
Combining either medication with opioids can cause profound sedation, slowed breathing, coma, or death. That warning appears prominently on both labels, and it is one reason prescribers ask carefully about pain medications.
Alcohol carries a similar concern. So do other sedating medications, including some sleep aids, muscle relaxants, and antihistamines.
Dependence, Withdrawal, and the FDA Boxed Warning
In September 2020, the FDA required an updated boxed warning for every benzodiazepine, including lorazepam and diazepam. This was made necessary as the existing labeling did not adequately convey the risks of misuse, addiction, physical dependence, and withdrawal.
The boxed warning contains two specific points. First, physical dependence can develop when benzodiazepines are taken steadily for several days to weeks, even exactly as prescribed. This is more so with higher doses or prolonged treatment. Dependence is not the same thing as addiction; it only indicates that the body has adapted to functioning a certain way in the presence of the medication. Addiction, on the other hand, involves compulsive use, psychological cravings, and a lack of control.
Second, stopping suddenly or cutting the dose too quickly can produce withdrawal reactions that include seizures, which can be life-threatening.
This is why tapering matters. Anyone who has been taking either medication regularly should generally work with their prescriber on a gradual reduction plan rather than stopping on their own.
The FDA labels for both lorazepam and diazepam note that their effectiveness beyond four months has not been established in systematic studies, which is part of why benzodiazepines are typically framed as short-term tools rather than indefinite treatments.
Which One Might Be a Better Fit?
There is no universal answer, and no head-to-head trial declares one drug superior for anxiety. Prescribers weigh several factors:
Liver function: Lorazepam is generally preferred when liver function is impaired, since it bypasses the enzyme system that processes most other benzodiazepines.
Other medications: Lorazepam has fewer significant drug interactions compared to diazepam, which simplifies things for people on complex regimens.
Muscle spasm: Diazepam is approved for spasticity and muscle spasm, so it may cover two problems at once.
Age: Intermediate-duration benzodiazepines such as lorazepam are often preferred for older adults because of drug accumulation and fall risk. Lorazepam’s relatively shorter half-life makes it a safer choice in such cases.
Coverage across the day: Diazepam’s longer duration may mean fewer doses, while lorazepam offers more predictable on and off timing.
Seizure care: Both are used in seizure emergencies, and the choice usually depends on the clinical setting and route of administration. There is a difference, though: lorazepam is approved for treating seizure emergencies such as status epilepticus, while diazepam is suitable as an adjunct medication in seizures.
Worth flagging: much of this comparison rests on pharmacology rather than on direct comparative trials in anxiety. The evidence for which benzodiazepine works better for anxiety specifically is thinner than most people assume, so individual response and side effect tolerance often end up carrying more weight than any published ranking.
Non-Benzodiazepine Alternatives Worth Discussing
Because of dependence concerns, prescribers may start with options that carry less long-term risk, especially when anxiety is ongoing rather than episodic.
SSRIs and SNRIs are considered first-line medication treatment for most anxiety disorders, though they generally take several weeks to work. Non-addictive anxiety medications such as buspirone and hydroxyzine may also be options, along with beta blockers like propranolol for situational physical symptoms. Some prescribers use gabapentin off-label, though the evidence there is thinner.
Therapy, particularly cognitive behavioral therapy, has strong evidence for anxiety disorders and may be used alongside or instead of medication. In fact, current clinical guidelines recommend cognitive behavioral therapy as one of the first-line treatments for many anxiety disorders.Ongoing anxiety often responds better to a combined approach than to medication alone.
When to Contact Your Prescriber
Reach out promptly if you notice unusual drowsiness, confusion, difficulty breathing, or trouble staying awake. Those can indicate a dose that is too high or an interaction with something else you are taking.
It is also worth checking in if you find yourself needing the medication more often than prescribed, if the same dose seems less effective than it used to be, or if you are anxious about stopping. None of those are reasons for embarrassment, and all of them are easier to address early than late.
How to Get Help
If anxiety is affecting your daily life and you are weighing medication options, a licensed psychiatric provider can assess your needs and decide if benzodiazepines are a good option for you. They will monitor you over the course of treatment and adjust dosage to the minimum levels needed to be effective. You can schedule a virtual visit with a Blossom Health provider covered by in-network insurance and typically be seen within days.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always talk with your physician or another qualified healthcare provider about any questions regarding a medical condition or medication. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
Ghiasi N, Bhansali RK, Marwaha R. Lorazepam. [Updated 2024 May 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532890/
Dhaliwal JS, Rosani A, Saadabadi A. Diazepam. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537022/
Bounds CG, Patel P. Benzodiazepines. [Updated 2024 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470159/
Cleveland Clinic. (2023, January 3). Benzodiazepines (benzos): What they are, uses, side effects & risks. https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos
Kang M, Galuska MA, Ghassemzadeh S. Benzodiazepine Toxicity. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482238/
U.S. Food and Drug Administration. (2023, August). Ativan (lorazepam) tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf
U.S. Food and Drug Administration. (2023, October). Valium (diazepam) tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s098lbl.pdf
U.S. Food and Drug Administration. (2020, September 23). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
National Institute of Mental Health. (2024, December). Anxiety disorders. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/anxiety-disorders
National Institute of Mental Health. (2023, December). Mental health medications. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/mental-health-medications
